India Anti-Fungal Drugs Market Booming to Cross USD 2.9 Billion by 2031

Published | 16 September 2025

India Anti-Fungal Drugs Market is flourishing primarily due to rising infections, government support, healthcare expansion, and increasing drug innovations.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India Anti-Fungal Drugs Market size by value at USD 1,543.86 million in 2024. During the forecast period between 2025 and 2031, BlueWeave expects India Anti-Fungal Drugs Market size to boom at a robust CAGR of 9.50%, reaching a value of USD 2,914.11 million by 2031. The expansion of India Anti-Fungal Drugs Market is driven by rising fungal infections due to poor hygiene, increasing immunocompromised populations, and hospital-acquired diseases. The surge in mucormycosis cases post-COVID-19 has intensified demand for effective treatments. Growing awareness among healthcare professionals, improved diagnostic capabilities, and easy access to over-the-counter medications further support market expansion. Additionally, supportive government health initiatives, rising disposable income, and expanding healthcare infrastructure in rural and urban areas contribute to the steady growth of India Anti-Fungal Drugs Market across the country.

Opportunity – Expansion of Generic Drug Manufacturing for Affordability

The expansion of generic drug manufacturing in India has significantly boosted the affordability and accessibility of anti-fungal treatments. Domestic pharmaceutical companies are producing cost-effective alternatives to branded drugs, reducing treatment expenses for patients across income levels. This shift is especially impactful in rural and semi-urban regions, where affordability is crucial. Regulatory support and competitive pricing have encouraged wider adoption of generics, strengthening India’s position as a global hub for affordable anti-fungal drug production. It, in turn, is expected to boost the growth of India Anti-Fungal Drugs Market in the coming years.

Sample Request: https://www.blueweaveconsulting.com/report/india-anti-fungal-drugs-market/report-sample

Topical Formulations Segment Accounts Largest Market Share ​

The topical formulations segment is expected to witness the most significant growth in India Anti-Fungal Drugs Market. Their dominance stems from ease of use, minimal systemic side effects, and effectiveness in treating common dermatological fungal infections like dermatophytosis. Topical drugs allow direct application to affected areas, require fewer doses, and are widely available over the counter. Rising awareness, humid climate conditions, and increasing skin-related fungal cases across India further reinforce the popularity of topical anti-fungal treatments.

Impact of Escalating Geopolitical Tensions on India Anti-Fungal Drugs Market 

Escalating geopolitical tensions have disrupted global pharmaceutical supply chains, impacting India Anti-Fungal Drugs Market. India imports over 60% of its active pharmaceutical ingredients (APIs), primarily from China. Trade restrictions, tariff uncertainties, and diplomatic strains have increased production costs and delayed drug availability. These challenges push Indian manufacturers to diversify sourcing and invest in domestic API production. While the market remains resilient, prolonged instability could hinder innovation, pricing, and timely access to essential anti-fungal therapies across healthcare settings.

Competitive Landscape

India Anti-Fungal Drugs Market is highly fragmented, with numerous players serving the market. Major companies dominating the market include Sun Pharmaceutical Industries Ltd, Cipla Ltd, Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories, Lupin Ltd, Aurobindo Pharma, Torrent Pharmaceuticals, Zydus Lifesciences Ltd, Alkem Laboratories, Pfizer India, and Abbott India Ltd. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in India Anti-Fungal Drugs Market.

Don’t miss the business opportunity in India Anti-Fungal Drugs Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and India Anti-Fungal Drugs Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India Anti-Fungal Drugs Market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Scope of the Report

About Us

BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com